Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 5/20 | 0.34 |
| ▸ | NPC1 | O15118 | 5/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | EDNRA | P25101 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
| ▸ | CA6 | P23280 | 1/20 | 0.30 |
| ▸ | CA5A | P35218 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26065245 | 0.85 | NPC1 (0.32) | RAB9ANPC1ALDH1A1MAPK1LMNA | |
| SCHEMBL15741229 | 0.85 | RAB9A (0.35) | RAB9ANPC1ALDH1A1MAPK1LMNA | |
| SCHEMBL17119432 | 0.82 | KDM4E (0.41) | RAB9ANPC1ALDH1A1MAPK1LMNA | |
| SCHEMBL19121885 | 0.81 | RAB9A (0.31) | RAB9ANPC1ALDH1A1MAPK1KMT2A | |
| SCHEMBL19743792 | 0.80 | CHRNA7 (0.35) | — | |
| SCHEMBL27884572 | 0.76 | TDP1 (0.34) | RAB9ANPC1ALDH1A1MAPK1 | |
| SCHEMBL12570324 | 0.75 | NOS3 (0.48) | ALDH1A1TSHRKDM4EMAPT | |
| SCHEMBL8008974 | 0.74 | TDP1 (0.36) | TSHRKDM4E | |
| SCHEMBL29265373 | 0.74 | ELANE (0.34) | ALDH1A1KMT2AKDM4E | |
| SCHEMBL19744110 | 0.74 | RAB9A (0.33) | RAB9ANPC1ALDH1A1MAPK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230020507-A1 | COMPOUND AND USE THEREOF IN TREATING AUTOIMMUNE DISEASES | PARENCHYMA BIOTECH INC. (KR) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230020507-A1 | COMPOUND AND USE THEREOF IN TREATING AUTOIMMUNE DISEASES | VIP, BACH1, IL17A | RAB9A 1377/4885NPC1 4142/4885ALDH1A1 841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.